KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Short term Debt (2016 - 2025)

Historic Short term Debt for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $1.4 billion.

  • Medtronic's Short term Debt fell 6181.77% to $1.4 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $1.4 billion, marking a year-over-year decrease of 6181.77%. This contributed to the annual value of $2.9 billion for FY2025, which is 16318.68% up from last year.
  • Per Medtronic's latest filing, its Short term Debt stood at $1.4 billion for Q4 2025, which was down 6181.77% from $2.4 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's Short term Debt registered a high of $5.9 billion during Q1 2023, and its lowest value of $6.0 million during Q3 2021.
  • Its 5-year average for Short term Debt is $2.2 billion, with a median of $1.5 billion in 2024.
  • In the last 5 years, Medtronic's Short term Debt tumbled by 9989.7% in 2021 and then soared by 9538333.33% in 2022.
  • Medtronic's Short term Debt (Quarter) stood at $16.0 million in 2021, then surged by 36550.0% to $5.9 billion in 2022, then tumbled by 77.17% to $1.3 billion in 2023, then soared by 177.74% to $3.7 billion in 2024, then tumbled by 61.82% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q4 2025, $2.4 billion for Q3 2025, and $2.9 billion during Q2 2025.